In summary, the present study illustrated that CXCL3 is highly expressed in HNSCC, and its up-regulated expression is closely related to the poor clinical characteristics of HNSCC, thus can be served as an adverse independent prognostic factor for patients with HNSCC. This evidence concerns the gene CXCL3 and head and neck squamous cell carcinoma.